The US Food and Drug Administration (FDA) is confronted with significant challenges in its inspection processes due to recent layoffs. Among ...

The US FDA is coping with a series of Trump-imposed job cuts. These are starting to hamper food safety and pharmaceutical ...

The Food and Drug Administration is scrambling to hire contractors to replace fired employees who helped plan thousands of ...

Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies are disrupting the work of drug, ...

WASHINGTON — Staffing has grown seven times faster than enrollment over the past five years at D.C. Public Schools, an internal audit found, but data management issues made staffing decisions ...

The biotech stakeholders are urging the Senate HELP committee to restore FDA staffing levels to maintain established regulatory timelines and consistency. “We are lucky to be developing ...

Johns Hopkins surgeon and writer Dr Martin Makary, President Donald Trump's pick to lead the FDA, faced a grilling ... would be taking the lead on FDA staffing levels. "If confirmed as ...

Amgen has its first direct competition in the KRAS inhibitor class following FDA approval of Mirati's adagrasib as Krazati for a form of lung cancer. Krazati has been cleared as a treatment for ...